Relapse Prevention During Opioid Treatment: What the Research Says

Relapse prevention is the part of opioid treatment aimed at lowering the chance of a return to use, and at dealing with a relapse if one occurs. Research treats opioid use disorder as a chronic condition, so a relapse is read as a signal to adjust treatment rather than proof that it failed. Counseling, peer and recovery support, and medication all play a part.

What does relapse prevention mean?

In practice, it means planning for the situations that raise the risk of using again, and building supports that help you through them. The National Institute on Drug Abuse (NIDA) describes relapse as a return to drug use after an attempt to stop. It says newer treatments are designed to help with relapse prevention. [Source: National Institute on Drug Abuse 2020]

The risk can last a long time. NIDA's research-based treatment guide explains that drug use changes the brain in ways that persist long after use stops. That may explain why relapse risk remains even after long periods without use. Stress at work, family problems, pain from a medical condition and reminders of past use, such as people, streets, objects or even smells, can all trigger intense cravings. Sometimes that happens without the person even being aware of what set it off. [Source: National Institute on Drug Abuse 2018]

Does relapse mean treatment has failed?

No. NIDA's answer to that question is a plain no. It explains that because addiction is chronic, relapse can be part of the process for some people. Relapse rates for drug use, it adds, are similar to rates for other chronic medical illnesses. [Source: National Institute on Drug Abuse 2020]

NIDA compares relapse in substance use disorders with relapse in high blood pressure and asthma. It concludes that substance use disorders should be treated like any other chronic illness. Relapse, in NIDA's words, "serves as a sign for resumed, modified, or new treatment," not as proof of failure. [Source: National Institute on Drug Abuse 2020]

"Addiction is a disease, not a character flaw," the Centers for Disease Control and Prevention (CDC) says. [Source: Centers for Disease Control and Prevention 2024] If you have relapsed before, that history is useful information for your care team, not a verdict on you.

None of this makes relapse harmless. NIDA warns that with opioids, relapse can be very dangerous or even deadly. After a period without use, the body is no longer used to its previous level of exposure. Using as much as before can then more easily lead to an overdose. In an emergency, NIDA's guidance is to call 9-1-1. In a substance use or mental health crisis, you can call or text 988 to reach the 988 Suicide & Crisis Lifeline. [Source: National Institute on Drug Abuse 2025]

What supports help prevent relapse during opioid treatment?

Counseling, peer support, recovery support services and medication all have backing from research or federal rules, and they are often used together. NIDA's research-based guide says a person may need different combinations of services over the course of treatment and recovery. [Source: National Institute on Drug Abuse 2018]

Counseling is where much of the day-to-day work happens, whether in individual counseling or group counseling. NIDA says behavioral therapies help people handle stressful situations and triggers, and can help them stay in treatment longer. [Source: National Institute on Drug Abuse 2020]

Federal rules define recovery support services broadly, from community-based recovery housing and peer recovery support to social support and coordination among service providers. [Source: 42 CFR 8.2, eCFR 2026] A program's care plan must also include the recovery support services a patient needs and wishes to pursue. [Source: 42 CFR 8.12, eCFR 2026]

How does medication fit into relapse prevention?

For opioid use disorder, medication is usually the starting point. NIDA says research shows medication should be the first line of treatment for opioid addiction, usually combined with behavioral therapy or counseling. It adds that medications can help people stay in treatment and avoid relapse. [Source: National Institute on Drug Abuse 2020]

NIDA explains that methadone reduces withdrawal symptoms and drug cravings while producing less intense feelings of pleasure in people with opioid use disorder. [Source: National Institute on Drug Abuse 2025] The CDC says medications for opioid use disorder help people reduce illegal opioid use, stay in treatment longer and lower their risk of an opioid-involved overdose. [Source: Centers for Disease Control and Prevention 2024]

Federal rules also require opioid treatment programs to provide counseling, including recovery-oriented counseling, as clinically necessary and agreed with each patient. [Source: 42 CFR 8.12, eCFR 2026] Questions about your own medication, including whether it is working for you, belong with your clinician.

How do you talk to your care team about relapse?

Bring it up early and plainly, as part of planning rather than only after a hard week. Federal rules say a program's care plan must include your goals and mutually agreed-upon actions to meet them. The plan must also be reviewed and updated as your needs and your life change. [Source: 42 CFR 8.12, eCFR 2026] NIDA's guide adds that a treatment plan should be developed cooperatively, with expectations clearly understood. [Source: National Institute on Drug Abuse 2018]

NIDA says a return to use is a sign to talk with your healthcare provider about resuming or modifying your treatment plan. [Source: National Institute on Drug Abuse 2025] Questions like these can open the conversation:

• Which situations in my week carry the most risk, and how do we plan for them?
• Which counseling, group or recovery support options fit my goals?
• How will we know if my plan needs to change?
• If I use again, who do I tell, and what happens next?

How Mile High Treatment & Recovery can help

We are an opioid treatment program at 6310 E. Exposition Ave in Denver, accredited by CARF, and we provide methadone.

• Support alongside medication. Our services include methadone therapy, medication-assisted treatment, individual and group counseling, recovery support services and care coordination.
• Hours. Weekday dosing runs Monday to Friday from 5:30 AM to 12:30 PM, and we are open Saturday from 9 to 11 AM.
• Your first visit. You can call ahead or walk in before 11:30 AM. Every new patient has an assessment before treatment begins, and what to expect at your first visit covers it step by step.
• Coverage. We accept Medicaid and Medicare, including Health First Colorado, Colorado Access, Colorado Community Health Alliance and Rocky Mountain Health Plans. We also offer a sliding scale if you are paying for yourself. See the plans we accept.

Relapse prevention: common questions

Is relapse prevention the same for everyone?

No. NIDA's research-based guide says no single treatment is appropriate for everyone, and that each person's treatment plan must be assessed continually and modified as needed. [Source: National Institute on Drug Abuse 2018] Federal rules take the same view, requiring services tailored to each patient through an individualized assessment and shared decision making. [Source: 42 CFR 8.12, eCFR 2026] So two people in the same program can have very different plans. The triggers, supports and goals that matter most to you are a good place to start when you and your care team build yours.

Are support groups the same as treatment?

No, though they can sit alongside it. NIDA describes mutual help groups as peer-led organizations that connect people with peers in recovery. Because they are not led by healthcare professionals, NIDA says they are not the same as treatment. Unlike most treatment, though, they are free and not time-limited, and many people find them useful on their own or in addition to professional care. [Source: National Institute on Drug Abuse 2025] If peer support interests you, ask your care team how it could fit with your counseling.

Does a relapse mean starting over?

Not in the way many people fear. NIDA's guide describes recovery as a long-term process that frequently requires multiple episodes of treatment. It says that relapses, as with other chronic illnesses, should signal a need for treatment to be reinstated or adjusted. [Source: National Institute on Drug Abuse 2018] A relapse gives you and your care team new information about what the plan needs. What happens next is something to work out with your care team, based on what you have both learned and what you want from treatment now.

Why is drug testing part of treatment?

Federal rules require opioid treatment programs to carry out random drug testing, using tests that have FDA marketing authorization. [Source: 42 CFR 8.12, eCFR 2026] NIDA's guide explains why monitoring matters. Knowing that drug use is being monitored can be a powerful incentive and can help people withstand urges to use. Monitoring also gives an early sign of a return to use, which can signal a need to adjust the treatment plan. [Source: National Institute on Drug Abuse 2018] Seen that way, a result is information for the next conversation with your care team.

Where to go from here

Relapse prevention is not a plan you write once. It is part of treatment, revisited with your care team as your needs change, and supported by counseling, peers and, for opioid use disorder, medication. This article is general education, not medical advice.

If you are in the Denver area and want to talk it through, call us at 720-756-7162 or get in touch. Still comparing programs? Our guide to methadone clinics in Colorado covers what to check first.